NIMOTOP 10MG-50ML Infusion Solution for infusion Arab Saudi - Inggeris - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

nimotop 10mg-50ml infusion solution for infusion

bayer pharma ag, germany - nimodipine - solution for infusion - 0.2 mg/ml

Nimotop New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

nimotop

bayer new zealand limited - nimodipine 30mg - film coated tablet - 30 mg - active: nimodipine 30mg excipient: crospovidone hypromellose iron oxide yellow macrogol 4000 magnesium stearate maize starch microcrystalline cellulose povidone titanium dioxide - after a preceding infusion of nimotop concentrated intravenous infusion solution, for:- prophylaxis and treatment of ischaemic neurological deficits caused by cerebral vasospasm following subarachnoid haemorrhage of aneurysmal origin. patients should be in good neurological condition post-ictus.

NIMOTOP FOR INFUSION 0.02% Singapura - Inggeris - HSA (Health Sciences Authority)

nimotop for infusion 0.02%

bayer (south east asia) pte ltd - nimodipine - injection - 0.02% - nimodipine 0.02%

Nimotop 10 mg/ 50 mL Solution For Infusion (Iv) Filipina - Inggeris - FDA (Food And Drug Administration)

nimotop 10 mg/ 50 ml solution for infusion (iv)

bayer philippines, inc.; distributor: bayer philippines, inc. - nimodipine - solution for infusion (iv) - 10 mg/ 50 ml

Nimotop 10 mg/ 50 mL Solution For Infusion (IV) Filipina - Inggeris - FDA (Food And Drug Administration)

nimotop 10 mg/ 50 ml solution for infusion (iv)

bayer philippines, inc. - nimodipine - solution for infusion (iv) - 10 mg/ 50 ml

NIMOTOP nimodipine 30 mg tablets blister pack Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

nimotop nimodipine 30 mg tablets blister pack

bayer australia ltd - nimodipine, quantity: 30 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; povidone; maize starch; crospovidone; magnesium stearate; hypromellose; macrogol 4000; iron oxide yellow; titanium dioxide - prophylaxis and treatment of ischaemic neurological deficits caused by cerebral vasospasm after subarachnoid haemorrhage following ruptured intracranial aneurysm, in patients who are in good neurological condition post-ictus (eg hunt and hess grades i-iii).

NIMOTOP Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

nimotop

bayer australia ltd - nimodipine -

Nimotop 30 mg film-coated tablets Ireland - Inggeris - HPRA (Health Products Regulatory Authority)

nimotop 30 mg film-coated tablets

bayer limited - nimodipine - film-coated tablet - 30 milligram(s) - dihydropyridine derivatives; nimodipine

Nimotop 10 mg/50 ml inf. sol. i.v. Belgium - Inggeris - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

nimotop 10 mg/50 ml inf. sol. i.v.

bayer sa-nv - nimodipine 0,01 g/50 ml - solution for infusion - 10 mg - 50 ml - nimodipine 10 mg - nimodipine

Nimotop IV Namibia - Inggeris - Namibia Medicines Regulatory Council

nimotop iv

bayer (pty) ltd - nimodipine - infusion - nimodipine solution 10mg/50ml